VENOUS THROMBOEMBOLISM
Clinical trials for VENOUS THROMBOEMBOLISM explained in plain language.
Never miss a new study
Get alerted when new VENOUS THROMBOEMBOLISM trials appear
Sign up with your email to follow new studies for VENOUS THROMBOEMBOLISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood thinner study in kids ends early after only 6 patients
Disease control TerminatedThis study looked at the safety and effectiveness of Pradaxa oral pellets for treating blood clots or preventing them from coming back in children aged 3 months to 12 years. The study was stopped early and only enrolled 6 participants. It aimed to track bleeding events and other …
Matched conditions: VENOUS THROMBOEMBOLISM
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
New blood thinner tested for cancer clot prevention, study halted early
Disease control TerminatedThis study tested a new blood thinner, abelacimab, against a standard one (dalteparin) in 417 adults with gastrointestinal or genitourinary cancers who also had blood clots. The goal was to see which drug better prevented new clots and caused less bleeding. The trial was terminat…
Matched conditions: VENOUS THROMBOEMBOLISM
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New blood thinner tested for cancer patients at risk of clots
Disease control TerminatedThis study tested a new blood thinner called abelacimab against the standard drug apixaban in about 1,150 people with cancer who had a blood clot (VTE). The goal was to see which drug better prevents new clots and causes less bleeding. The trial was stopped early, so final result…
Matched conditions: VENOUS THROMBOEMBOLISM
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New PET probe aims to spot dangerous clots
Diagnosis TerminatedThis study tested a new PET scan dye that sticks to fresh blood clots in people with pulmonary embolism (PE) and deep vein thrombosis (DVT). Six adults received the dye within 72 hours of diagnosis, and doctors used PET-CT to see if the dye could find clots in the lungs, thighs, …
Matched conditions: VENOUS THROMBOEMBOLISM
Phase: PHASE1 • Sponsor: Peter Caravan • Aim: Diagnosis
Last updated May 26, 2026 05:03 UTC
-
Blood clot study seeks clues to lasting leg and lung damage
Knowledge-focused TerminatedThis study looked at how platelets (small blood cells) might cause long-term problems after a blood clot, like leg pain or breathing issues. Researchers measured certain markers on platelets in 44 adults with recent clots. The goal was to find out why some people recover fully wh…
Matched conditions: VENOUS THROMBOEMBOLISM
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated May 26, 2026 05:07 UTC